Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105).
Dai MaruyamaShinsuke IidaRyunosuke MachidaShigeru KusumotoNoriko FukuharaNobuhiko YamauchiKana MiyazakiMakoto YoshimitsuJunya KurodaNorifumi TsukamotoHideki TsujimuraKensuke UsukiTakahiro YamauchiTakahiko UtsumiIshikazu MizunoYasushi TakamatsuYasuyuki NagataShuichi OtaEiichi OhtsukaIchiro HanamuraYasuhiro SuzukiShinichiro YoshidaSatoshi YamasakiYouko SuehiroYutaro KamiyamaSuguru FukuharaKunihiro TsukasakiHirokazu NagaiPublished in: Cancer science (2022)